Advertisement
Advertisement

RNAZ

RNAZ logo

TransCode Therapeutics, Inc. Common Stock

4.89
USD
Sponsored
+0.04
+0.82%
Jun 24, 16:00 UTC -4
Closed
exchange

After-Market

4.91

+0.01
+0.20%

TransCode Therapeutics, Inc. Common Stock Profile

About

TransCode Therapeutics is an emerging RNA oncology company. Its platform of investigational drug candidates is dedicated to improving patient outcomes encompassing a variety of tumor types. The company's lead therapeutic candidate includes TTX-MC138. TransCode Therapeutics is based in BOSTON.

Info & Links

CEO

Philippe P. Calais

Headquarters

6 Liberty Square, #2382
Boston, MA 02109, UNITED STATES

Industry

Medical Drugs

Sector

Medical

Website

www.transcodetherapeutics.com

Auditor

WithumSmith+Brown, PC

Share holders

--

Employees

12

TransCode Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

4.66M

Enterprise Value

-8.17M

Enterprise Value/EBITDA(ttm)

0.19

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

5.00

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-440.64%

Return on Invested Capital(ttm)

-234.47%

Return on Assets(ttm)

-205.50%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-42.48M

Net Income Available to Common(ttm)

-43.70M

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

1.49

52-Week Change

-34.73%

S&P 500 52-Week Change

20.78%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

950.30K

Dividend Yield

0.00%

Float4

917.00K

% Held by Insiders

0.01%

% Held by Institutions

0.00%

Balance Sheet

Total Cash(mrq)

12.84M

Total Cash Per Share(mrq)

13.51

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

1.60%

Quick Ratio(mrq)

1.60%

Book Value Per Share(mrq)

1.71

Cash Flow

Operating Cash Flow Per Share(ytd)

-13.64

Free Cash Flow(ytd)

-11.37M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement